Notre Dame Advanced Diagnostics and Therapeutics | Mar. 11, 2013
A potential landmark paper by Notre Dame researchers could help identify and adjust important parameters for designing targeted nanoparticle-based cancer treatments for years to come.
The results of the study shed light on a decades-long debate among cancer researchers.
The paper is authored by Jared Stefanick, Jonathan Ashley, Tanyel Kiziltepe, and Basar Bilgicer.